RXL vs. CURE
Compare and contrast key facts about ProShares Ultra Health Care (RXL) and Direxion Daily Healthcare Bull 3x Shares (CURE).
RXL and CURE are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. RXL is a passively managed fund by ProShares that tracks the performance of the Dow Jones U.S. Health Care Index (200%). It was launched on Jan 30, 2007. CURE is a passively managed fund by Direxion that tracks the performance of the Health Care Select Sector Index (300%). It was launched on Jun 15, 2011. Both RXL and CURE are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: RXL or CURE.
Performance
RXL vs. CURE - Performance Comparison
Returns By Period
In the year-to-date period, RXL achieves a 3.95% return, which is significantly higher than CURE's 0.81% return. Over the past 10 years, RXL has underperformed CURE with an annualized return of 12.32%, while CURE has yielded a comparatively higher 13.42% annualized return.
RXL
3.95%
-14.95%
-7.70%
17.09%
11.04%
12.32%
CURE
0.81%
-21.53%
-14.14%
20.85%
10.76%
13.42%
Key characteristics
| RXL | CURE | |
|---|---|---|
| Sharpe Ratio | 0.82 | 0.67 |
| Sortino Ratio | 1.20 | 1.08 |
| Omega Ratio | 1.16 | 1.14 |
| Calmar Ratio | 0.64 | 0.53 |
| Martin Ratio | 3.21 | 2.55 |
| Ulcer Index | 5.56% | 8.46% |
| Daily Std Dev | 21.63% | 32.07% |
| Max Drawdown | -66.88% | -69.19% |
| Current Drawdown | -19.18% | -28.66% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
RXL vs. CURE - Expense Ratio Comparison
RXL has a 0.95% expense ratio, which is lower than CURE's 1.08% expense ratio.
Correlation
The correlation between RXL and CURE is 0.96, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Risk-Adjusted Performance
RXL vs. CURE - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for ProShares Ultra Health Care (RXL) and Direxion Daily Healthcare Bull 3x Shares (CURE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
RXL vs. CURE - Dividend Comparison
RXL's dividend yield for the trailing twelve months is around 1.19%, less than CURE's 1.51% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
RXL ProShares Ultra Health Care | 1.19% | 0.18% | 0.65% | 0.16% | 0.25% | 0.43% | 0.52% | 0.23% | 0.23% | 1.83% | 0.40% | 0.31% |
CURE Direxion Daily Healthcare Bull 3x Shares | 1.51% | 2.02% | 0.38% | 0.02% | 0.17% | 0.40% | 0.70% | 0.18% | 0.00% | 0.00% | 0.00% | 1.24% |
Drawdowns
RXL vs. CURE - Drawdown Comparison
The maximum RXL drawdown since its inception was -66.88%, roughly equal to the maximum CURE drawdown of -69.19%. Use the drawdown chart below to compare losses from any high point for RXL and CURE. For additional features, visit the drawdowns tool.
Volatility
RXL vs. CURE - Volatility Comparison
The current volatility for ProShares Ultra Health Care (RXL) is 7.11%, while Direxion Daily Healthcare Bull 3x Shares (CURE) has a volatility of 10.51%. This indicates that RXL experiences smaller price fluctuations and is considered to be less risky than CURE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.